'Open Health Data in Practice: Increase Your Access to Lab Results: Voice Your Support for a Proposed Federal Rule That Expands Patients' Access to Test Results.'

Tim OReilly

首页> 外文期刊>Information today >'Open Health Data in Practice: Increase Your Access to Lab Results: Voice Your Support for a Proposed Federal Rule That Expands Patients' Access to Test Results.'

【24h】

'Open Health Data in Practice: Increase Your Access to Lab Results: Voice Your Support for a Proposed Federal Rule That Expands Patients' Access to Test Results.'

机译：“在实践中开放健康数据：增加您获得实验室结果的机会：支持拟议的联邦法规，扩大患者对检测结果的获取。”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

I'm convinced that there's a wave of innovation coming in healthcare, driven by new kinds of data, new ways of extracting meaning from that data, and new business models that data can enable. That's one of the reasons why we launched our StrataRx Conference, which focuses on the importance of data science to the future of health care.

机译：我坚信，医疗保健领域将迎来一波创新浪潮，它受到新数据类型，从数据中提取含义的新方法以及数据可以实现的新业务模型的推动。这就是我们启动StrataRx大会的原因之一，该大会专注于数据科学对未来医疗保健的重要性。

著录项

来源
《Information today》 |2012年第11期|19-19|共1页
作者
Tim OReilly;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. HHS Proposes Rule to Expand Rights of Patients Seeking Access to Personal Health Information - Clinical Lab Products [J] . Clinical Lab Products . 2011,第2011期

机译：HHS提出规则，扩大寻求获得个人健康信息的患者的权利-临床实验室产品
2. HHS Proposes Rule to Expand Rights of Patients Seeking Access to Personal Health Information - Clinical Lab Products [J] . Clinical Lab Products . 2011,第2011期

机译：HHS提出规则，扩大寻求获得个人健康信息的患者的权利-临床实验室产品
3. Feasibility of Using a Community-Supported Agriculture Program to Increase Access to and Intake of Vegetables among Federally Qualified Health Center Patients [J] . Izumi Betty T., Higgins Cesar E., Baron Andrea, Journal of Nutrition Education and Behavior . 2018,第3期

机译：使用社区支持的农业计划的可行性，以增加联邦合格的保健中心患者中蔬菜的访问和摄入量
4. Accessible Mobile Application to Support Self Testing for Anticoagulated Patients using a Personal Health Record Appliying Good Practices [C] . Adrian Casado-Rivas, Lourdes Moreno Lopez, Paloma Martinez Fernandez, International Conference on Health Informatics . 2014

机译：可访问的移动应用，以支持使用个人健康记录应用良好实践的抗凝患者自我测试
5. Engaging surgeons in transformational change: How can a partnership between surgeons and Fraser Health lead to expanded surgical capacity and greater access to surgery for patients? [D] . Lawson, David E. 2005

机译：让外科医生参与变革变革：外科医生与Fraser Health之间的合作关系如何扩大手术能力并为患者提供更多的手术机会？
6. Access to Oral Health Care: The Role of Federally Qualified Health Centers in Addressing Disparities and Expanding Access [O] . Emily Jones, Leiyu Shi, Arthur Seiji Hayashi, 2013

机译：获得口腔保健服务：联邦合格的医疗中心在解决差距和扩大获得机会方面的作用
7. The bacterial identification and antimicrobial susceptibility testing are usually performed manually. Recently, the number of samples has increased and the need for automatification has grown. BioMerieux has investigated Vitek2 for this purpose. HUSLAB has assigned us to compare the identification and antimicrobial results with respect to routine methods and Vitek2. Furthermore, we evaluate test reactions, ESBL (Extended Spectrum Beta-Lactamase) production and the time what it takes to get results with Vitek2. In this study, we examined a total of 183 bacterial isolates including 76 ESBL-strains, 40 nonfermenting rods, 41 fastidious bacteria and 26 fresh clinical isolates. The results of routine methods were gathered from the patient database and following this, compared to the results given by Vitek2. Vitek2 correctly identified more than 96 f the ESBL-strains and fresh clinical isolates. The results of nonfermenting rods and fastidious bacteri a were 70 oncordant with those of the routine methods. Test reaction results of Api20E were 94 nd Api20NE 70 n concordance with Vitek2 results. Approximately 80 f all Vitek2 antimicrobial results and 90 f ESBL test results were correct. Compared to earlier studies, Vitek2 performed the tests faster than the routine methods. These results suggest that Vitek2 is capable of giving rapid and accurate results. However, nonfermenting rods and fastidious bacteria should be studied further. [O] . Järveläinen Marika, Roslund Iira, Silander Maarit 2006

机译：细菌鉴定和抗菌药敏试验通常是手动进行的。最近，样品的数量增加了，并且对自动化的需求也在增长。 BioMerieux为此进行了Vitek2的研究。 HUSLAB已指派我们比较常规方法和Vitek2的鉴定和抗菌结果。此外，我们还评估了测试反应，ESBL（扩展频谱β-内酰胺酶）的产生以及使用Vitek2获得结果所需的时间。在这项研究中，我们检查了总共183个细菌分离株，包括76个ESBL菌株，40个非发酵棒，41个营养细菌和26个新鲜临床分离株。从患者数据库中收集常规方法的结果，然后将其与Vitek2给出的结果进行比较。 Vitek2正确鉴定出超过96种ESBL菌株和新鲜的临床分离株。与常规方法相比，非发酵棒和精制细菌的结果为70。 Api20E的测试反应结果与Vitek2结果一致为94nd Api20NE 70 n。所有Vitek2抗菌结果约80 f和ESBL测试结果90 f正确。与早期的研究相比，Vitek2的测试速度快于常规方法。这些结果表明Vitek2能够给出快速而准确的结果。但是，应进一步研究非发酵棒和营养细菌。

'Open Health Data in Practice: Increase Your Access to Lab Results: Voice Your Support for a Proposed Federal Rule That Expands Patients' Access to Test Results.'

摘要

著录项

相似文献

相关主题

期刊订阅